Current challenges in the management of breast cancer brain metastases
O’Sullivan, Ciara C., Davarpanah, Nicole N., Abraham, Jame, Bates, Susan E.
Published in Seminars in oncology (01.04.2017)
Published in Seminars in oncology (01.04.2017)
Get full text
Journal Article
Immunotherapy: a new treatment paradigm in bladder cancer
Davarpanah, Nicole N, Yuno, Akira, Trepel, Jane B, Apolo, Andrea B
Published in Current opinion in oncology (01.05.2017)
Published in Current opinion in oncology (01.05.2017)
Get more information
Journal Article
Neurotoxicities associated with checkpoint inhibitors: Two case reports and a review of the literature
Cordes, Lisa M., Davarpanah, Nicole N., Reoma, Lauren B., Gasmi, Billel, Quezado, Martha, Khan, Omar I., Nath, Avindra, Apolo, Andrea B.
Published in Clinical case reports (01.01.2020)
Published in Clinical case reports (01.01.2020)
Get full text
Journal Article
Adjuvant atezolizumab versus observation in muscle-invasive urothelial carcinoma (IMvigor010): a multicentre, open-label, randomised, phase 3 trial
Bellmunt, Joaquim, Hussain, Maha, Gschwend, Jürgen E, Albers, Peter, Oudard, Stephane, Castellano, Daniel, Daneshmand, Siamak, Nishiyama, Hiroyuki, Majchrowicz, Martin, Degaonkar, Viraj, Shi, Yi, Mariathasan, Sanjeev, Grivas, Petros, Drakaki, Alexandra, O'Donnell, Peter H, Rosenberg, Jonathan E, Geynisman, Daniel M, Petrylak, Daniel P, Hoffman-Censits, Jean, Bedke, Jens, Kalebasty, Arash Rezazadeh, Zakharia, Yousef, van der Heijden, Michiel S, Sternberg, Cora N, Davarpanah, Nicole N, Powles, Thomas
Published in The lancet oncology (01.04.2021)
Published in The lancet oncology (01.04.2021)
Get full text
Journal Article
Phase I Study of Cabozantinib and Nivolumab Alone or With Ipilimumab for Advanced or Metastatic Urothelial Carcinoma and Other Genitourinary Tumors
Apolo, Andrea B, Nadal, Rosa, Girardi, Daniel M, Niglio, Scot A, Ley, Lisa, Cordes, Lisa M, Steinberg, Seth M, Sierra Ortiz, Olena, Cadena, Jacqueline, Diaz, Carlos, Mallek, Marissa, Davarpanah, Nicole N, Costello, Rene, Trepel, Jane B, Lee, Min-Jung, Merino, Maria J, Bagheri, Mohammad Hadi, Monk, Paul, Figg, William D, Gulley, James L, Agarwal, Piyush K, Valera, Vladimir, Chalfin, Heather J, Jones, Jennifer, Streicher, Howard, Wright, John J, Ning, Yangmin M, Parnes, Howard L, Dahut, William L, Bottaro, Donald P, Lara, Jr, Primo N, Saraiya, Biren, Pal, Sumanta K, Stein, Mark N, Mortazavi, Amir
Published in Journal of clinical oncology (01.11.2020)
Published in Journal of clinical oncology (01.11.2020)
Get full text
Journal Article
Cabozantinib in patients with platinum-refractory metastatic urothelial carcinoma: an open-label, single-centre, phase 2 trial
Apolo, Andrea B, Nadal, Rosa, Tomita, Yusuke, Davarpanah, Nicole N, Cordes, Lisa M, Steinberg, Seth M, Cao, Liang, Parnes, Howard L, Costello, Rene, Merino, Maria J, Folio, Les R, Lindenberg, Liza, Raffeld, Mark, Lin, Jeffrey, Lee, Min-Jung, Lee, Sunmin, Alarcon, Sylvia V, Yuno, Akira, Dawson, Nancy A, Allette, Kimaada, Roy, Arpita, De Silva, Dinuka, Lee, Molly M, Sissung, Tristan M, Figg, William D, Agarwal, Piyush K, Wright, John J, Ning, Yangmin M, Gulley, James L, Dahut, William L, Bottaro, Donald P, Trepel, Jane B
Published in The lancet oncology (01.08.2020)
Published in The lancet oncology (01.08.2020)
Get full text
Journal Article
IMvigor010: Primary analysis from a phase III randomized study of adjuvant atezolizumab (atezo) versus observation (obs) in high-risk muscle-invasive urothelial carcinoma (MIUC)
Hussain, Maha H. A., Powles, Thomas, Albers, Peter, Castellano, Daniel, Daneshmand, Siamak, Gschwend, Juergen, Nishiyama, Hiroyuki, Oudard, Stephane, Tayama, Darren, Davarpanah, Nicole N., Degaonkar, Viraj, Shi, Yi, Mariathasan, Sanjeev, Grivas, Petros, O'Donnell, Peter H., Rosenberg, Jonathan E., Geynisman, Daniel M., Hoffman-Censits, Jean H., Petrylak, Daniel Peter, Bellmunt, Joaquim
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
Elevating the Horizon: Emerging Molecular and Genomic Targets in the Treatment of Advanced Urothelial Carcinoma
Kurtoglu, Metin, Davarpanah, Nicole N, Qin, Rui, Powles, Thomas, Rosenberg, Jonathan E, Apolo, Andrea B
Published in Clinical genitourinary cancer (01.10.2015)
Published in Clinical genitourinary cancer (01.10.2015)
Get full text
Journal Article
Molecular residual disease (MRD) detection with a tissue comprehensive genomic profiling (CGP)-informed personalized monitoring assay: An exploratory analysis of the IMvigor-010 observation arm
Young, Amanda, Nimeiri, Halla, Madison, Russell, Fine, Alexander D., Zollinger, Daniel, Gjoerup, Ole, Aushev, Vasily N., Wu, Hsin-Ta, Aleshin, Alexey, Davarpanah, Nicole N., Assaf, Zoe, Mariathasan, Sanjeev, Oxnard, Geoffrey R., Renkonen, Elise, Powles, Thomas, Hegde, Priti
Published in Journal of clinical oncology (20.02.2022)
Published in Journal of clinical oncology (20.02.2022)
Get full text
Journal Article
Atezolizumab (atezo) with or without Bacille Calmette-Guérin (BCG) in patients (pts) with high-risk nonmuscle-invasive bladder cancer (NMIBC): Results from a phase Ib/II study
Hahn, Noah M., Steinberg, Gary D., Stratton, Kelly Lynn, Kopp, Ryan P., Sankin, Alexander, Skinner, Eila C., Pohar, Kamal S., Gartrell, Benjamin Adam, Pham, Song, Rishipathak, Deepali, Mariathasan, Sanjeev, Davarpanah, Nicole N., Carter, Corey, Inman, Brant Allen
Published in Journal of clinical oncology (20.02.2022)
Published in Journal of clinical oncology (20.02.2022)
Get full text
Journal Article
Treatment (tx) characteristics of patients (pts) with locally advanced or metastatic urothelial cancer (mUC) receiving checkpoint inhibitor (CPI) monotherapy in a US clinical practice
Morgans, Alicia K., Rahma, Osama E., Mhatre, Shivani K., Chuo, Ching-Yi, Davies, Jessica, Martinalbo, Jorge, Davarpanah, Nicole N., Pachynski, Russell
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article
Treatment (tx) characteristics of patients (pts) with locally advanced or metastatic urothelial cancer (mUC) receiving atezolizumab (atezo) monotherapy in United States clinical practice
Mhatre, Shivani K., Chuo, Ching-Yi, Morgans, Alicia K., Rahma, Osama E., Pachynski, Russell Kent, Martinalbo, Jorge, Davarpanah, Nicole N., Davies, Jessica
Published in Journal of clinical oncology (01.03.2019)
Published in Journal of clinical oncology (01.03.2019)
Get full text
Journal Article
A pilot clinical trial of genomic-based therapy assignment with co-expression extrapolation (COXEN) in advanced/metastatic urothelial carcinoma
Niglio, Scot Anthony, Nadal, Rosa Maria, Cordes, Lisa M., Steinberg, Seth M., Davarpanah, Nicole N., Costello, Rene, Mallek, Marissa, Girardi, Daniel da Motta, Merino, Maria, Wang, Yonghong, Mannheimer, Joshua, Edelman, Daniel, Walling, Jennifer, Meltzer, Paul S., Theodorescu, Dan, Gustafson, Daniel, Apolo, Andrea B.
Published in Journal of clinical oncology (20.02.2021)
Published in Journal of clinical oncology (20.02.2021)
Get full text
Journal Article
Cabozantinib and peripheral immunity in advanced urothelial carcinoma: Final results from an open-label, phase II trial
Apolo, Andrea B., Nadal, Rosa, Tomita, Yusuke, Davarpanah, Nicole N., Cordes, Lisa M., Steinberg, Seth M., Cao, Liang, Parnes, Howard L., Costello, Rene, Merino, Maria J., Folio, Les R., Lindenberg, Liza, Raffeld, Mark, Lin, Jeffrey, Lee, Min-Jung, Lee, Sunmin, Alarcon, Sylvia V., Yuno, Akira, Dawson, Nancy A., Allette, Kimaada, Roy, Arpita, De Silva, Dinuka, Lee, Molly M., Sissung, Tristan M., Figg, William D., Agarwal, Piyush K., Wright, John J., Ning, Yangmin M., Gulley, James L., Dahut, William L., Bottaro, Donald P., Trepel, Jane B.
Published in The lancet oncology (06.07.2020)
Published in The lancet oncology (06.07.2020)
Get full text
Journal Article
18 F-FDG-PET/CT imaging to assess response to treatment with cabozantinib at 4 weeks versus 8 weeks of therapy in patients (pts) with metastatic urothelial carcinoma (mUC)
Davarpanah, Nicole N., Lindenberg, Liza, Paul, Dereck W, Steinberg, Seth M., Francis, Deneise C, Berniger, Marilise Anne, Weaver, Juanita, McKinney, Yolanda, Parnes, Howard L., Choyke, Peter L., Apolo, Andrea B.
Published in Journal of clinical oncology (20.02.2017)
Published in Journal of clinical oncology (20.02.2017)
Get full text
Journal Article
Assessing bone response to cabozantinib in patients (pts) with metastatic urothelial carcinoma (mUC) using 18 F-Sodium Fluoride (NaF) PET/CT
Lin, Jeffrey, Lindenberg, Liza, Steinberg, Seth M., McKinney, Yolanda, Weaver, Juanita, Francis, Deneise C, Berniger, Marilise Anne, Parnes, Howard L., Davarpanah, Nicole N., Choyke, Peter L., Apolo, Andrea B.
Published in Journal of clinical oncology (20.02.2017)
Published in Journal of clinical oncology (20.02.2017)
Get full text
Journal Article
Results of phase I plus expansion cohorts of cabozantinib (Cabo) plus nivolumab (Nivo) and CaboNivo plus ipilimumab (Ipi) in patients (pts) with with metastatic urothelial carcinoma (mUC) and other genitourinary (GU) malignancies
Nadal, Rosa Maria, Mortazavi, Amir, Stein, Mark, Pal, Sumanta K., Davarpanah, Nicole N., Parnes, Howard L., Ning, Yang-Min, Cordes, Lisa M., Bagheri, Mohammadhadi H., Lindenberg, Liza, Thompson, Ryan, Steinberg, Seth M., Moore, Tina, Lancaster, Tiffany, Velez, Milisyaris, Mena, Esther, Costello, Rene, Bottaro, Donald, Dahut, William L., Apolo, Andrea B.
Published in Journal of clinical oncology (20.02.2018)
Published in Journal of clinical oncology (20.02.2018)
Get full text
Journal Article
A phase I study of cabozantinib plus nivolumab (CaboNivo) and cabonivo plus ipilimumab (CaboNivoIpi) in patients (pts) with refractory metastatic (m) urothelial carcinoma (UC) and other genitourinary (GU) tumors
Apolo, Andrea B., Mortazavi, Amir, Stein, Mark N., Davarpanah, Nicole N., Nadal, Rosa Maria, Parnes, Howard L., Ning, Yangmin M., Francis, Deneise C, Cordes, Lisa M, Berniger, Marilise Anne, Steinberg, Seth M., Agarwal, Piyush K., Bagheri, Mohammadhadi H., Nanda, Swati, Monk, Paul, Lancaster, Tiffany, Moore, Tina, Costello, Rene, Bottaro, Donald P., Pal, Sumanta K.
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article
Combined FDG and NaF PET/CT study in patients (pts) with metastatic genitourinary tumors (mGU) treated with cabozantinib + nivolumab +/- ipilimumab (CaboNivo+/-Ipi)
Lin, Jeffrey, Mortazavi, Amir, Stein, Mark N., Pal, Sumanta K., Davarpanah, Nicole N., Nadal, Rosa Maria, Francis, Deneise C, Berniger, Marilise Anne, Monk, Paul, Kempf, Jeffrey, Becker, Murray, Sokol, Levi, McKinney, Yolanda, Knopp, Michael V., Wright, Chadwick, Jung, Alex, Choyke, Peter L., Mena, Esther, Lindenberg, Liza, Apolo, Andrea B.
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article
A phase I study of cabozantinib plus nivolumab (CaboNivo) and ipilimumab (CaboNivoIpi) in patients (pts) with refractory metastatic urothelial carcinoma (mUC) and other genitourinary (GU) tumors
Apolo, Andrea B., Mortazavi, Amir, Stein, Mark N., Pal, Sumanta K., Davarpanah, Nicole N., Parnes, Howard L., Ning, Yangmin M., Francis, Deneise C, Cordes, Lisa M, Monk, Paul, Lancaster, Tiffany, Costello, Rene, Nanda, Swati, Bottaro, Donald P., Wright, John Joseph, Streicher, Howard, Steinberg, Seth M., Berninger, Marilise, Lindenberg, Liza, Dahut, William L.
Published in Journal of clinical oncology (20.02.2017)
Published in Journal of clinical oncology (20.02.2017)
Get full text
Journal Article